Literature DB >> 14065076

EFFECT OF CHLORPROTHIXENE IN PATIENTS WITH PARANOID SYMPTOMS.

C H CAHN.   

Abstract

Chlorprothixene, a thioxanthine derivative, claimed to have broad-spectrum antipsychotic properties, was compared with phenothiazine derivatives in the setting of a psychiatric admission service and aftercare clinic.In 32 female patients with paranoid symptoms, chlorprothixene in high dosage ranges (200 to 1200 mg. daily) was found to be as effective as similar doses of chlorpromazine in controlling the symptoms; fewer side effects were noted.

Entities:  

Keywords:  CHLORPROTHIXENE; PARANOIA; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1963        PMID: 14065076      PMCID: PMC1921988     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  Clinical evaluation of chlorprothixene.

Authors:  P E FELDMAN
Journal:  Am J Psychiatry       Date:  1960-04       Impact factor: 18.112

2.  [Introduction to the pharmacology of taractan, a neuroleptic with a special mechanism of action].

Authors:  B PELLMONT; F A STEINER; H BESENDORF; H P BAECHTOLD; E LAEUPPI
Journal:  Schweiz Med Wochenschr       Date:  1960-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.